In 2012, the Board of the UICC has approved the convening of a Global Task Force on Radiotherapy for Cancer Control (GTFRCC) to under their purpose – “…to unite the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.” This was in recognition of that by 2030 with 70% of all cancer deaths will occur in lower and middle-income countries – countries ill-equipped to handle this pending crisis. Many of these countries have limited or no radiotherapy capacity despite RT being required in 50% of all cancer cases for to cure or control the disease locally.

The GTFRCC brought together cancer leaders together with radiotherapy professionals, industry partners, cancer control organizations, patient groups, economists, and enablers of healthcare change, which sought to identify the current gap in radiotherapy and the cost to close that gap by 2035. It also embarked on an economic analysis of the problem and the economic impact of investing into RT.

Structures & Goals

The GTFRCC developed an investment framework that identified:

  1. The global burden of cancer amenable to radiation therapy,
  2. The core investments required to provide radiation services, including facilities, equipment, human resources investments, and education to sustain and grow the service.
  3. The outcomes that might be expected from a global investment in radiation, including lives saved, patients palliated, and the economic benefits that could be expected.

Three smaller working groups within the general Task Force determined the inputs in the framework. Other investments, either in health care (enabling services), or societal infrastructure (contextual readiness) will be informed through broad consultation with other stakeholders but was not form part of the core investment calculation.

GTFRCC Membership

Adewole, Isaac | Ibadan, Nigeria
Al Hammadi, Noora | Doha, Qatar
Al Saleh, Khaled | Kuwait
Anacak, Yavuz | Izmir, Turkey
Anderson, Ben | Seattle, United States
Asirwa, Chite | Eldoret, Kenya
Audisio, Riccardo | 9YcgVcVO, United Kingdom
Badwe, Rajendra | Mumbai, India
Bartelink, Harry | Amsterdam, Netherlands
Barton, Michael | Sydney, Australia
Baumann, Michael | Dresden, Germany
Bentzen, Soren | Baltimore, United States
Billimaga, Ramesh | Bangalore, India
Booth, Christopher | Kingston, Canada
Buchholz, Tom | Houston, United States
Camacho, Rolando | Vienna, Austria
Cavalli, Franco | Bellinzona, Switzerland
Cazap, Eduardo | Buenos Aires, Argentina
Choi, Eun Kyung | Seoul, Korea, South
Coffey, Mary | Dublin, Ireland
Coleman, Norman | Bethesda, United States
Collingridge, David | London, United Kingdom
Cordova, Adres | Temuco, Chile
De La Torre, Marcela | ALATRO, Argentina
DeWeese, Ted | Baltimore, United States
Delaney, Geoff | Sydney, Australia
Demaio, Sandro | Boston, United States
Duchesne, Gillian | East Melbourne, Australia
Efstathiou, Jason | Boston, United States
El Zawawy, Ahmed | Egypt
Engel-Hills, Penelope | Cape Town, South Africa
Enwerem-Bromson, Nelly | Vienna, Austria

Ginsburg, Ophira | Toronto, Canada
Gondhowiardjo, Soehartati | Jakarta, Indonesia
Gospodarowicz, Mary | Toronto, Canada
Grau, Cai | Aarhus, Denmark
Grover, Surbhi | Philadelphia, United States
Hahn, Steve | Philadelphia, United States
Halvorsen, Per | United States
Hanna, Tim | Canada
Hoskin, Peter | London, United Kingdom
Hu, Kenneth | New York, United States
Ibn Seddik, Ahmed | Rabat , Morocco
Incrocci, Luca | Rotterdam, Netherlands
James Cox, James | Houston, United States
Jassem, Jacek | Gdańsk, Poland
Kadzatsa, Webster | Harare, Zimbabwe
Kennedy, Kolleen | Palo Alto, United States
Kerr, David | Oxford, United Kingdom
Kigula-Mugambe, Joseph | Kampala, Uganda
Kingham, Peter | New York, United States
Knaul, Felicia M. | Boston, United States
Kron, Tomas | Melbourne, Australia
Kutluk, Tezer | Turkey
Lee, Anne | Hong Kong
Leech, Michelle | Dublin, Ireland
Lievens, Yolande | Gent, Belgium
Linares, Luis | Guatemala City, Guatemala
Liu, Fei Fei | Toronto, Canada
Loehrer, Patrick | Indianapolis, United States
Low, Daniel | Los Angeles, United States
Lui, Tracey | Toronto, Canada
MacPherson, Miller | Toronto, Canada
Mijnheer, Ben | Amsterdam, Netherlands
Milosevic, Michael | Toronto, Canada
Morgan, Graeme | Sydney, Australia

Nakano, Takashi | Gunma , Japan
O’Sullivan, Brian | Toronto, Canada
Oluwole, Doyin | United States
Poortmans, Philip | Tilburg, Netherlands
Ricardi, Umberto | Turin, Italy
Rodin, Danielle | Toronto, Canada
Rosenblatt, Eduardo | Vienna, Austria
Sankaranarayanan, Rengaswamy | Lyon, France
Seong, Jinsil | Seoul, Korea, South
Sherar, Michael | Toronto, Canada
Shrivastava, Shyam | Mumbai, India
Sullivan, Richard | London, United Kingdom
Suneja, Gita | Philadelphia, United States
Tien, Joseph Wie Sing | Singapore
Trimble, Edward | Bethesda, United States
Tyldesley, Scott | Vancouver, Canada
Van De Velde, Cornelius | Leiden, Netherlands
Van Dyk, Jake | London, Canada
Venderpuye, Verna | Accra, Ghana
Vidaurre Rojas, Tatiana | Lima, Peru
Vikram, Bhadrasain | Bethesda, United States
Vázquez, Tabaré | Uruguay
Wild, Chris | Lyon, France
Yap, Mei Ling | Sydney, Australia
Yu, Jinming | Shandong, China
Zubizarreta, Eduardo | Vienna, Austria

Barton, Michael | Sydney, Australia
Bentzen, Soren | Baltimore, United States
Coleman, Norman | Bethesda, United States
Delaney, Geoff | Sydney, Australia
Grau, Cai | Aarhus, Denmark
Hanna, Tim | Canada
Rodin, Danielle | Toronto, Canada
Sankaranarayanan, Rengaswamy | Lyon, France
Tyldesley, Scott | Vancouver, Canada
Yap, Mei Ling | Sydney, Australia

Coffey, Mary | Dublin, Ireland
Cordova, Adres | Temuco, Chile
Engel-Hills, Penelope | Cape Town, South Africa
Jaffray, David | Toronto, Canada
Kigula-Mugambe, Joseph | Kampala, Uganda
Kron, Tomas | Melbourne, Australia
Leech, Michelle | Dublin, Ireland
Lievens, Yolande | Gent, Belgium
Lui, Tracey | Toronto, Canada
Mijnheer, Ben | Amsterdam, Netherlands
Milosevic, Michael | Toronto, Canada
Rosenblatt, Eduardo | Vienna, Austria
Van Dyk, Jake | London, Canada
Zubizarreta, Eduardo | Vienna, Austria

Past Events

The workshop introduced the problem of limited global availability of radiotherapy, reviewed the main methodologies and findings of the Global Task Force on Radiotherapy for Cancer Control (GTFRCC), and considered the implications of its findings for improved global access to radiotherapy.


The interactive nature of the workshop provided an opportunity for creative dialogue about strategies to achieve the goals outlined in the GTFRCC report (Lancet Oncology 2015). It also considered approaches to create a radiotherapy partnership that includes professional and civil society organizations, international and technical groups, and public and private funding sources in order to, drive activities at the state-level to close the gap in access to radiotherapy.

A report launch was held at Harvard University hosted by Dr. Rifat Atun.

The GTFRCC participated Radiotherapy and Chemotherapy session at the African Organisation for Research and Training in Cancer (AORTIC) Conference in Marrakech, Morocco. Several posters with the details of the study were also represented.

Dr. Mei Ling Yap delivered a talk at the 2015 Annual RANZCR meeting about the benefits of achieving equitable access to radiotherapy. See her talk here:

The GTFRCC unveiled their final results at the European Cancer Congress. The session featured the leads of the working groups to describe their findings and answer the questions:

  1. What is the cost to ensure global access to radiotherapy by 2035?
  2. Does an investment into radiotherapy translate into a positive economic return?

The formal talks were followed by a panel session discussing the results, the implications of our findings, and how to move forward with closing the inequity. For the full agenda click here.


Presentations from the session:

Economic Framework_GTFRCC_Atun

The Cancer Problem_Gospodarowicz

The Cost of Radiotherapy_Lievens

Innovations in Radiotherapy_Jaffray

The GTFRCC was invited to by Lancet Oncology to be one of their four commissions. The Global Radiotherapy Commission was launched at the Presidential Session at the European Cancer Congress in Vienna, Austria. Dr. Rifat Atun spoke on behalf of the Commission.

The GTFRCC presented their preliminary results at ESTRO. The agenda for the session can be found here.

The GTFRCC hosted a two-day workshop on March 8th and 9th, 2015. This by-invitation-only event was attended by a wide spectrum of individuals representing different regions and professions in oncology.

A working group meeting was held on March 8th. Here Drs. Michael Barton, Jake Van Dyk, and Rifat Atun presented the detailed outputs of their working groups. The inputs and assumptions of the working groups were examined in detail by other members of the GTFRCC. The goal was to have a consensus on the methodologies by the Task Force. Decisions on the most relevant sensitivity analyses were also made.

With an agreement on the results, how to turn results into action was explored on the second day of the workshop. Following a review of the work groups’ results, day 2 of was filled with discussion on how to present the results and stewardship of the GTFRCC following its closure at the end of 2015. Engagement strategies with other oncology commissions, professional organizations, and the global health initiatives were explored and targets for the Task Force were developed.

To see the agenda for the two-day workshop click here: GTFRCC Workshop March 8 & 9 Agenda_Final.

The GTFRCC had two major events planned at the World Cancer Congress (WCC). The GTFRCC’s work was featured at the World Cancer Leaders’ Summit on December 3rd, 2015. This by-invitation-only event featured Dr. Rifat Atun who presented preliminary results during the keynote session and a breakout session on radiotherapy co-hosted by Dr. Mary Gospodarowicz and Nelly Enwerem-Bromson. Dr. David Jaffray chaired the session with key members of the working groups on a panel to discuss the gap in radiotherapy, the cost of closing the inequity gap in various cancer control methods, and strategies to bring equal access to cancer care globally.

The GTFRCC also presented their preliminary results in a general session at the WCC on December 5th, 2014. The working groups presented their methodologies, initial findings and described what effect that investment will have on the global economy. A panel discussion was held after to discuss how to move these results forward to close the inequity gap in radiotherapy. Please click on the link to view the agenda: Agenda for the World Cancer Congress

We were excited to be part of the main program at ASTRO 2014. Leading up to the event the Red Journal had published a volume focused specifically the role of radiotherapy in developing nations (volume 89, no.3). With this spotlight, our work could not have come at a more appropriate time. Professional associations and specific institutions have programs to provide radiotherapy education people in LMICs. The IAEA has been working in LMICs to develop and build the infrastructure required to implement RT programs. Work is being done about the inequity problem. However, the radiotherapy community had yet to garner the attention of large healthcare organizations who have the ability to make sweeping changes.

How do we make radiotherapy a global health priority? What are the global health milestones that the radiotherapy community should be striving to meet? These questions and more were open for discussion during our ASTRO session “Inserting Radiotherapy into the Global Health Movement”. Click here for the full agenda.

Presentations from the event are below:

Update on the GTFRCC, Dr. David Jaffray

The Global Health Movement, Dr. Gavin Yamey

The GTFRCC was focused on the global implementation of radiation therapy, but any solution to the cure and palliation of cancer requires the engagement of all parties involved in the entire course treatment. Effective approaches to the growing cancer problem will have to include innovative multi-stakeholder strategies that involve, amongst many other factors, cancer-specific services such as surgical and medical oncology, government funding for health, and patient and community education programs. If Low Middle-Income Countries (LMIC) are to experience the full benefits of radiation therapy it must integrate into broader healthcare system of that country. The session at ASCO enabled the Task Force to consult with non-radiotherapy experts for their options on how to solve the inequity problem.

Click here for the agenda and here for a session summary.

A special 5-hour GTFRCC symposium was held on April 4th, 2014 in conjunction with the ESTRO meeting in Vienna.   Speakers from the IAEA, ESTRO, industry, and members of the Task Force presented new data, programs, and data models that reflect the current state of cancer and radiotherapy globally, the initiatives to promote radiotherapy, and the current work of the task force. The day concluded with a spirited panel session that challenged key stakeholders to define near-term goals and advocacy strategies for the promotion, education, and implementation of radiation therapy

Held in Toronto on February 5-6, 2014, the Toronto Launch Meeting served to bring working group leads together with the GTFRCC Secretariat to review work plans, confirm assumptions, and set goals for the Task Force leading to its goal of reporting at the World Cancer Congress.

The meeting was kicked off with a special panel discussion at Princess Margaret Cancer Centre, featuring David Collingridge (Editor in Chief, Lancet Oncology), Felicia Knaul (Harvard Global Health Initiative), Michael Barton (CCORE, University of New South Wales),  Mary Gospodarowicz (Medical Director Princess Margaret Cancer Centre and President UICC), and moderated by David Jaffray.   Working group meetings were held on February 5th, and a joint meeting with the Secretariat was held on February 6th.

Agenda Toronto Launch Meeting

Summary from Toronto Meeting


Introduction to the Toronto Meeting

Global Task Force on Expanded Access to Cancer Care and Control

Radiotherapy Utilisation Rates

Populations Benefits of Optimal Radiotherapy Use


Radiotherapy Cost Estimator

Cancer Stage Presentation at LMIC

Investment Framework for Radiotherapy

On October 1st, 2013, 33 cancer leaders convened during the ECCO Congress in Amsterdam to discuss the need for greater access to radiotherapy, and the objectives of the GTFRCC. A summary of the meeting and the key messages can be found here.


Education and training programs to ensure there are enough trained professionals to deliver radiotherapy is just as important as ensuring there is enough radiotherapy equipment. It is clear that novel approached radiotherapy training must be implemented to facilitate the global needs for radiotherapy.

The aim of our education survey was to understand the current state of RT education, what training resources are currently available, and what are the challenges faced by countries that do not have enough trained professionals.


Select a button below to view the results of the educational surveys.

Education and training programs to ensure there are enough trained professionals to deliver radiotherapy is just as important as ensuring there is enough radiotherapy equipment. It is clear that novel approached radiotherapy training must be implemented to facilitate the global needs for radiotherapy.

The aim of our education survey was to understand the current state of RT education, what training resources are currently available, and what are the challenges faced by countries that do not have enough trained professionals.